Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 77 | 0 | 29 | 0 | 843,30 € | 900,00 € | 6,72 % |
| Biogen Inc. | 57 | 1 | 7 | 0 | 208,20 € | 291,49 € | 40,01 % |
| Boston Scientific | 57 | 0 | 10 | 0 | 70,50 € | 76,37 € | 8,32 % |
| Vertex Pharmaceuticals Inc. | 56 | 2 | 9 | 0 | 437,75 € | 439,24 € | 0,34 % |
| Regeneron Pharmaceuticals Inc. | 50 | 1 | 13 | 0 | 954,40 € | 1.048,1 € | 9,81 % |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | 231,70 € | 251,80 € | 8,68 % |
| Johnson & Johnson | 42 | 1 | 9 | 0 | 135,12 € | 179,00 € | 32,47 % |
| UnitedHealth Group Inc. | 41 | 1 | 7 | 0 | 450,10 € | 540,08 € | 19,99 % |
| AbbVie Inc. | 40 | 0 | 18 | 0 | 154,24 € | 176,57 € | 14,48 % |
| Novo Nordisk A/S ADR | 38 | 1 | 22 | 0 | 131,50 € | 150,00 € | 14,07 % |
| Intuitive Surgical Inc | 38 | 0 | 5 | 0 | 409,30 € | 396,68 € | -3,08 % |
| Thermo Fisher Scientific Inc. | 37 | 0 | 10 | 0 | 497,95 € | 565,20 € | 13,51 % |
| Insmed Inc. | 37 | 0 | 9 | 0 | 57,00 € | 68,37 € | 19,94 % |
| Pfizer Inc. | 35 | 4 | 8 | 0 | 25,87 € | 40,00 € | 54,62 % |
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | 50,50 € | 83,56 € | 65,47 % |
| Merck & Co. Inc. | 34 | 1 | 6 | 0 | 116,60 € | 125,34 € | 7,49 % |
| Tenet Healthcare | 34 | 0 | 2 | 0 | 122,00 € | 129,16 € | 5,87 % |
| Intra-Cellular Therapies Inc. | 34 | 0 | 9 | 0 | 64,50 € | 84,35 € | 30,77 % |
| Amgen Inc. | 33 | 0 | 9 | 0 | 286,70 € | 304,82 € | 6,32 % |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | 128,30 € | 140,87 € | 9,80 % |
| HCA Holdings Inc. | 30 | 0 | 4 | 0 | 295,40 € | 307,81 € | 4,20 % |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | 14,93 € | 31,00 € | 107,66 % |
| Edwards Lifesciences Corp. | 27 | 1 | 0 | 0 | 85,17 € | 88,21 € | 3,57 % |
| Trinity Biotech ADR | 25 | 0 | 3 | 0 | 0,41 € | - | - |
| Stryker Corp. | 25 | 1 | 1 | 1 | 311,00 € | 337,58 € | 8,55 % |